![]() |
市場調查報告書
商品編碼
1372034
到 2030 年免疫保健補充劑市場預測:按產品類型、來源、型態、配銷通路、客戶意願、型態、用途和地區進行的全球分析Immune Health Supplements Market Forecasts to 2030 - Global Analysis By Product Type, Source, Form, Distribution Channel, Customer Orientation, Mode of Medication, Application and By Geography |
根據 Stratistics MRC 的數據,2023 年全球免疫保健補充劑市場規模為 711 億美元,預計預測期內年複合成長率為 13.4%,到 2030 年將達到 1,714 億美元。
免疫補充食品是食品支持和增強人體免疫系統的營養補充,這些補充劑通常含有被認為可以增強對病原體和外部威脅的免疫反應的維生素和礦物質、抗氧化劑和天然化合物。常見成分包括維生素 C、維生素 D、鋅、紫錐菊和益生菌,可降低疾病風險並幫助從感染疾病和疾病中恢復。
根據《營養商業雜誌》報道,2020 年 4 月免疫補充劑的購買量大幅增加也就不足為奇了。
由於健康意識的提高、生活方式的改變和體重管理計劃的增加等要素,預計該市場將會擴大。例如,人們從每天消費的食品和飲料中尋求額外的好處和安全。此外,營養補充食品確保滿足您所有營養需求的有用且實用的方法。因此,在預測期內,對免疫保健補充劑的需求可能會增加。
這項技術由感測器、設備和軟體結構,需要大量的初期成本來獲取和部署。此外,持續的維護、培訓和系統更新也會增加總擁有成本。對於預算有限的醫療保健機構和其他機構來說,這種成本可能會成為障礙並阻礙普及。儘管減少醫療保健相關感染和提高病患安全具有長期好處,但一些公司可能會發現初期成本成為採用手部衛生監測系統的障礙。因此,這些要素正在阻礙市場的成長。
顧客逐漸收集被認為能夠增強身體防禦力和免疫力的有效產品。此外,免疫保健品製造商正在確定哪些物質具有臨床上確定的益處,因為消費者高度重視自己的健康。此外,製造商對製作保健品的基本補充食品需求量很大,例如益生菌、omega-3 脂肪酸、接骨木果和蘑菇。此外,免疫保健補充食品的研發也不斷擴大,食品提供真正有效的增強免疫力的營養補充。因此,這些要素是市場擴張的主要驅動力。
當藥物與其他藥物混合或在手術前服用時,免疫系統會發生變化。對於患有某些醫學問題的人來說,增強免疫力的補充劑也可能會產生問題。此外,許多補充劑的效果尚未在兒童或孕婦中進行研究,這些補充劑被視為食品而不是食品。此外,補充劑的品質和對身體的影響尚未經過食品藥物管理局的評估。營養補充的包裝盒上也沒有列出潛在的副作用列表,也沒有關於所選錠劑尺寸指南的法規。老年人面臨的風險更大,市場規模不斷縮小。
免疫保健補充食品市場受到了 COVID-19大流行的不利影響。然而,由於製造限制、供應鏈中斷和法規不確定性,市場遇到了困難。封鎖、旅遊限制和經濟不確定性影響了消費者購買力和個人支出,導致銷售下降。此外,人們的興趣已從免疫補充劑轉向疫苗接種和 COVID-19 藥物治療。因此,這些因素綜合起來,導致疫情期間免疫保健食品的市場擴張放緩。
由於使用營養補充食品來改善整體健康和增強免疫功能,維生素和礦物質補充劑領域預計將佔據最大佔有率。此外,雖然與手部衛生監測技術無關,但本節強調了感染控制綜合策略的價值。此外,透過保持足夠量的重要維生素和礦物質,醫療保健專業人員和個人可以增強身體對感染的天然防禦能力,透過營養供給促進身體健康並減少感染的脆弱性。這支持手部衛生監測工作,突顯感染的複雜性預防和健康維護。
由於肥皂和消毒劑等手部衛生產品中使用植物來源物質,預計植物性細分市場在預測期內將呈現最高的年複合成長率。此外,這種市場區隔錶明,客戶對錶達永續性和天然成分理想的產品越來越偏好,並且與環保實踐的更廣泛趨勢相一致,增加了提供相容的植物來源部衛生產品的價值。因此,這些方面都在逐步加大市場規模。
由於人口成長和購買力上升,亞太地區在估計期間佔據了最大的市場佔有率,最終促進了保健補充食品市場的擴張。此外,亞太地區既是銀杏葉等原料的來源地,也是新產品線的靈感來源,包括基於印度阿育吠陀和傳統醫學的草藥滋補品和飲料。此外,自我藥療在該地區比西方競爭更為普及,這對非處方藥產業產生了顯著的正面影響。對阿育吠陀等傳統產品的需求正在吸引國際和本地投資者來到亞太地區,將出口集中到需求中心。因此,這些方面最終推動了市場的擴張。
預計北美在預測期內將實現盈利成長。例如,根據美國疾病管制與預防中心 (CDC) 的數據,約有 3,420 萬美國患有糖尿病,而美國8,800 萬成年人(約佔美國的三分之一)患有糖尿病前期。因此,隨著人們健康意識的增強,預計北美將繼續主導免疫保健品市場。
According to Stratistics MRC, the Global Immune Health Supplements Market is accounted for $71.1 billion in 2023 and is expected to reach $171.4 billion by 2030 growing at a CAGR of 13.4% during the forecast period. Immune health supplements are dietary products formulated to support and strengthen the body's immune system, these supplements typically contain a combination of vitamins, minerals, antioxidants, and natural compounds that are believed to enhance the immune response to pathogens and external threats. Common ingredients include vitamin C, vitamin D, zinc, echinacea, and probiotics, which help in reduce the risk of illness, and aid in recovery from infections or diseases.
According to the Nutrition Business Journal, not surprisingly, the purchase of immune supplements in April 2020 surged significantly.
The market is projected to rise as a result of factors such as rising health awareness, changing lifestyles, and an increase in weight management programs. For instance, people seek out additional advantages or safety from the foods and drinks they consume every day. Furthermore, dietary supplements are a helpful and practical way to guarantee that all nutritional demands are met. It follows that during the forecast period, demand for immune health supplements is likely to increase.
The technology, which comprises sensors, equipment, and software, can require a substantial initial expenditure in order to acquire and implement. Moreover, the total cost of ownership is also increased by continuing upkeep, training, and system updates. Healthcare facilities and other institutions with limited budgets may find this expense to be an obstacle, which would prevent widespread adoption. Some businesses may view the initial cost as an obstacle to adopting Hand Hygiene Monitoring Systems, despite the long-term advantages in terms of decreased healthcare-associated infections and increased patient safety. Therefore, these factors hampers the growth of the market.
Customers are progressively collecting effective products that they think can boost defence and immunity in the body. Additionally, immunity health supplement makers are deciding on substances that would have clinically established advantages because consumers place a high priority on health. Moreover, manufacturers have a significant demand for essential ingredients needed to make health supplements like probiotics, omega-3 fatty acids, elderberry, and button mushrooms. Furthermore, research and development efforts on immune health supplements are expanding consistently to provide really efficient dietary supplements for immunity-boosting purposes. Therefore, these factors significantly drive the market expansion.
Immune system will have changes when mixed with other medications or taken before surgery, several supplements which may cause negative side effects. For people with specific medical issues, immunity-boosting supplements can also be problematic. Additionally, many supplements' effects haven't been studied in children, pregnant women, or other groups, these supplements are controlled as foods rather than medications. Furthermore, the quality of supplements and their effects on the body are not evaluated by the Food and Drug Administration. There are no regulations on the list of potential side effects on the box of dietary supplements or guidelines for the chosen tablet size. Thus, as a result, the older population is being put at great risk, thereby hampering the market size.
On the market for immune health supplements, the COVID-19 pandemic has had a detrimental effect. However, as a result of manufacturing limitations, supply chain disruptions, and regulatory uncertainty, the market encountered difficulties. Lockdowns, travel restrictions, and economic uncertainty all had an effect on consumer purchasing power and personal expenditure, which resulted in a drop in sales. Moreover, in addition, attention was diverted from immune health supplements in favor of vaccinations and pharmacological therapies for COVID-19. Therefore, these elements combined to cause a slowdown in the market's expansion for immune health supplements during the epidemic.
The vitamins & minerals supplements segment is estimated to hold the largest share, due to the use of dietary supplements to improve general wellness and boost immune function. Additionally, even though it has nothing to do with hand hygiene monitoring technology, this section emphasizes the value of an all-encompassing strategy for infection management. Moreover, the body's natural defences against infections can be strengthened by ensuring healthcare workers and individuals maintain proper quantities of vital vitamins and minerals, it emphasizes the complex nature of infection prevention and health maintenance by encouraging good health through nutritional supplementation and minimizing vulnerability to infections, which supports hand hygiene monitoring activities.
The plant based segment is anticipated to have highest CAGR during the forecast period, due to the use of substances derived from plants in hand hygiene products like soaps and sanitizers, an eco-aware approach to hand hygiene is provided by these sustainable, cruelty-free, and environmentally friendly solutions. Moreover, this market segment shows a growing customer preference for goods that represent their ideals of sustainability and all-natural components, in line with a broader trend toward environmentally friendly practices, it emphasizes the value of providing plant-based hand hygiene products to cater to eco-conscious individuals and businesses. Therefore, these aspects gradually propel the market size.
Asia Pacific commanded the largest market share during the extrapolated period owing to the population growth and rising purchasing power have ultimately aided in the expansion of the health supplement market. Additionally, the Asia-Pacific area serves as a source of raw materials like ginkgo biloba as well as an inspiration for new product lines, including herbal tonics and beverages based on Indian Ayurveda and traditional Chinese medicine. Moreover, self-medication is becoming more popular in the region compared to western competitors, which has had a huge positive impact on the OTC industry. The demand for conventional goods like Ayurveda has drawn international and local investors to the Asia-Pacific area, where they are concentrating on exports to demand centers. Therefore, these aspects consequently drive the market expansion.
North America is expected to witness profitable growth over the projection period, owing to the people's rising awareness of these topics, it is anticipated that health and well-being will continue to be at the forefront in the near future. For instance, almost 34.2 million Americans have diabetes, according to the Centers for Disease Control and Prevention (CDC), and in the United States, 88 million adults, or about one-third of the population, have prediabetes, in addition, regional development would be sparked by the rising prevalence of lifestyle diseases like diabetes and obesity. Therefore, as people's awareness of their own wellbeing and health grows, it is projected that North America will continue to dominate the market for immune health supplements.
Some of the key players in the Immune Health Supplements Market include: Abbott Laboratories, American Health, Amway Corp, Bayer AG, Boehringer Ingelheim, Danone, GlaxoSmithKline Inc., Herbalife Nutrition of America, Inc., Himalaya Global Holdings Ltd., Nestle, Novartis, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Limited, Swisse Wellness Pty Ltd., The Nature's Bounty Co. and Unilever.
In September 2023, Nestle announced an agreement with Advent International to acquire a majority stake in Grupo CRM, a premium chocolate player in Brazil. Grupo CRM operates a successful direct-to-consumer model, with more than 1 000 chocolate boutiques under the Kopenhagen and Brasil Cacau brands and a strong, growing online presence.
In March 2023, Nestle and UNESCO announced a new partnership to provide young people with the resources and the skills they need to develop and carry forward innovative solutions to achieve positive social impact in their communities.
In July 2023, DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide (FALCON™) platform, announced that it has been acquired by Novartis.
Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.